RxDoctor Payments Data

Chad Wilson, MD

Surgery · Boston, MANPI 1386628949

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $864 of the $1,363 with a category attached, or 63.4%. 9 manufacturers reported payments, led by Zimmer Biomet at 43.6% of the total. Reporting peaked in 2021 at $670 and has fallen 89.6% since, to $70 in 2024. That places this record below the midpoint for surgery clinicians in MA, where the typical reported total is $1,048.

$1,363in general payments, 2019–2025

Across 35 payments — averaging $38.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$595
  • Davol Inc.$347
  • TELA Bio, Inc.$176
  • Portola Pharmaceuticals, LLC$64
  • Pfizer$58
  • Z-medica, LLC$45
  • plus $79 from 3 others
$361,807in research payments, 2019–2025

Across 25 payments — averaging $14,472 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • CSL Behring$362K

What the payments were for

  • Consulting fees$453%
  • Travel & lodging$44733%
  • Food & beverage$86463%
  • Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,363 in reported general payments places this provider in the 50th percentile of 694 surgery providers in Massachusetts.

See all surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$7,650
Medicare patients
13
Services billed
35

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →